MARKET

SONN

SONN

Sonnet Biotherapeutc Hldng Inc
NASDAQ
1.690
-0.130
-7.14%
Opening 14:23 04/22 EDT
OPEN
1.820
PREV CLOSE
1.820
HIGH
1.820
LOW
1.685
VOLUME
14.74K
TURNOVER
0
52 WEEK HIGH
26.40
52 WEEK LOW
1.080
MARKET CAP
5.19M
P/E (TTM)
-0.1309
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SONN last week (0415-0419)?
Weekly Report · 12h ago
Weekly Report: what happened at SONN last week (0408-0412)?
Weekly Report · 04/15 12:18
Weekly Report: what happened at SONN last week (0401-0405)?
Weekly Report · 04/08 12:23
Weekly Report: what happened at SONN last week (0325-0329)?
Weekly Report · 04/01 12:20
Weekly Report: what happened at SONN last week (0318-0322)?
Weekly Report · 03/25 12:23
Weekly Report: what happened at SONN last week (0311-0315)?
Weekly Report · 03/18 12:21
RNLX, ASLN and SONN among pre-market losers
Seeking Alpha · 03/12 12:28
Weekly Report: what happened at SONN last week (0304-0308)?
Weekly Report · 03/11 12:16
More
About SONN
Sonnet BioTherapeutics Holdings, Inc. is a clinical-stage, oncology-focused biotechnology company. The Company's technology, namely Fully Human Albumin Binding (FHAB), utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The Company designed the FHAB construct to improve drug accumulation in cancer tumors, as well as to extend the duration of activity in the body. Its lead asset, SON-1010, is a fully human single-chain version of Interleukin 12 (IL-12), covalently linked to the FHAB construct, for which it is pursuing clinical development in solid tumors. Its lead clinical-stage asset, SON-080, is a fully human version of IL-6 manufactured in Chinese Hamster Ovary (CHO) cells. SON-080, for its target indications of Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Diabetic Peripheral Neuropathy (DPN). Its pipeline also includes SON-1210, SON-1410 and SON-3015.

Webull offers Sonnet Biotherapeutics Holdings Inc stock information, including NASDAQ: SONN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SONN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SONN stock methods without spending real money on the virtual paper trading platform.